Xiaolan Hu

Summary

Affiliation: Pfizer Global Research and Development
Country: USA

Publications

  1. ncbi Genome-wide association study identifies multiple novel loci associated with disease progression in subjects with mild cognitive impairment
    X Hu
    PharmaTx Precision Medicine, Pfizer, Pfizer Global R and D, Groton, CT, USA
    Transl Psychiatry 1:e54. 2011
  2. ncbi Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease
    Xiaolan Hu
    Molecular Medicine, Pfizer Inc, Groton, Connecticut, United States of America
    PLoS ONE 6:e16616. 2011

Detail Information

Publications2

  1. ncbi Genome-wide association study identifies multiple novel loci associated with disease progression in subjects with mild cognitive impairment
    X Hu
    PharmaTx Precision Medicine, Pfizer, Pfizer Global R and D, Groton, CT, USA
    Transl Psychiatry 1:e54. 2011
    ....
  2. ncbi Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease
    Xiaolan Hu
    Molecular Medicine, Pfizer Inc, Groton, Connecticut, United States of America
    PLoS ONE 6:e16616. 2011
    ..Future experiments will help us better understand potential roles of these genetic loci in AD pathology...